ABC News Australia reports on pressure on the regulator to tighten rules on peptides that haven't been approved.
Recap by typeshit. Full story at ABC News (Australia).
AP sources say FDA scientists opposed the HHS draft telling the agency not to act against pharmacies compounding six wellness peptides. Comments are open for two weeks.
Law firm Frier Levitt reads the rule as single-ingredient only, so the popular blend stays out. Public Citizen and ex-FDA official Janet Woodcock voice safety concerns.
Six peptides can now be compounded under strict conditions, but HHS itself says that proves nothing on safety, and research-use-only sellers stay outside the policy.
Compounders get a pass on BPC-157, TB-500 and four others if they meet sourcing and reporting rules. The Alliance for Pharmacy Compounding cheers it, while Public Citizen calls it reckless.
Western Isles prescribes 10 times more than Shetland, and the ABPI says need doesn't explain the gap. It also found 71% of Scots on weight loss drugs went private.
Walmart and Bank of America are expanding coverage, while 10% of surveyed employers say they may drop it in 2027. Workers explain what coverage means for their budgets.
Loading…